Skip to main content

Table 2 – HIFU treatment technical details (n = 45)

From: Peri-operative, functional and early oncologic outcomes of salvage robotic-assisted radical prostatectomy after high-intensity focused ultrasound partial ablation

Ideal according to consensus criteria, n (%)

26 (57.8)

Prostate volume, median (IQR)

35 (27–46)

Location of treatment (combined treatment fields for n = 5 with 2 HIFU treatments)

 Hemi-gland unilateral

 

 Hemi-gland with extension across midline or into SV

16

 Hemi-gland anterior

7

 Hemi-gland posterior

1

 Quadrant (e.g. unilateral posterior)

1

 Focal ablation (eg posterior right basal segment)

13

 Subtotal (extended hemi-ablation, sparing lateral aspect of contralateral side)

6

1

Number of HIFU treatments

 1

37

 2

8

Known ‘insignificant’ cancer left untreated at HIFU

 Yes

21 (47.7)

 No

23 (52.3)

Type of biopsy pre-HIFU:

 TTMB TP 5 mm Mapping + MRI-Targeted (if targets)

24 (53.3)

 12–20 core TRUS + MR-targeted (if targets)

17 (37.8)

 Targeted alone

3 (6.7)

 Not documented

1 (2.2)